<DOC>
	<DOCNO>NCT00698425</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability single iontophoretic dose buffer solution administer EyeGate® II Drug Delivery System healthy adult human volunteer .</brief_summary>
	<brief_title>Safety Tolerability Study Transscleral Iontophoresis EyeGate® II Drug Delivery Device System</brief_title>
	<detailed_description>This single center , randomize , single-masked , comparative group , safety tolerability study single dose level citrate buffer deliver transcleral iontophoresis administer via EyeGate® II Drug Delivery System . The current study also determine safety tolerability dose range transcleral iontophoresis 2 mA 7 mA determine safety tolerability application Eyegate II system eye time range 10.5 minute .</detailed_description>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Healthy adult Normal ophthalmic examination eye Presence subjective ocular symptom Presence conjunctival hyperemia , chemosis , watering , conjunctival discharge Ocular trauma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>Iontophoresis</keyword>
	<keyword>Ophthalmology</keyword>
</DOC>